8 replies to this topic

[1kgcoffee]

The other recent topic got me thinking, whatever happened to alagebrium? The company seems to be in the gutter
http://www.google.ca...ance?q=OTC:SYNI

They appear to be developing a drug that mimics glutathione peroxidase? Anyone news on this company? I am going to be buying some stocks pretty soon, what do you think, is Synvista Therapeutics a good bet?

[Ghostrider]

The other recent topic got me thinking, whatever happened to alagebrium? The company seems to be in the gutter
http://www.google.ca...ance?q=OTC:SYNI

They appear to be developing a drug that mimics glutathione peroxidase? Anyone news on this company? I am going to be buying some stocks pretty soon, what do you think, is Synvista Therapeutics a good bet?

ALT used to be traded, I think it was on the NYSE, under ticker symbol ALT. I actually owned that stock for a very short time. I hope they can come out with something and save the company. I'll warn you although you probably already know this...biotech stocks are the hardest stocks to trade. You really need a lot of in-depth knowledge about biology in order to evaluate the companies you are dealing with. They can also be very volatile because there's a very random element to their successes and failures - government regulation, FDA approvals can make or break a small biotech company.

[1kgcoffee]

The other recent topic got me thinking, whatever happened to alagebrium? The company seems to be in the gutter
http://www.google.ca...ance?q=OTC:SYNI

They appear to be developing a drug that mimics glutathione peroxidase? Anyone news on this company? I am going to be buying some stocks pretty soon, what do you think, is Synvista Therapeutics a good bet?

ALT used to be traded, I think it was on the NYSE, under ticker symbol ALT. I actually owned that stock for a very short time. I hope they can come out with something and save the company. I'll warn you although you probably already know this...biotech stocks are the hardest stocks to trade. You really need a lot of in-depth knowledge about biology in order to evaluate the companies you are dealing with. They can also be very volatile because there's a very random element to their successes and failures - government regulation, FDA approvals can make or break a small biotech company.

Thanks for the response. You're right, and come to think of it, ALT is probably not a good pick at this time.. If 117 was a flop, they're most likely SOL.

That said, I won't miss the money and I'm willing to take some big risks. Any tips?

[resveratrol]

The other recent topic got me thinking, whatever happened to alagebrium? The company seems to be in the gutter
http://www.google.ca...ance?q=OTC:SYNI

They appear to be developing a drug that mimics glutathione peroxidase? Anyone news on this company? I am going to be buying some stocks pretty soon, what do you think, is Synvista Therapeutics a good bet?

ALT used to be traded, I think it was on the NYSE, under ticker symbol ALT. I actually owned that stock for a very short time. I hope they can come out with something and save the company. I'll warn you although you probably already know this...biotech stocks are the hardest stocks to trade. You really need a lot of in-depth knowledge about biology in order to evaluate the companies you are dealing with. They can also be very volatile because there's a very random element to their successes and failures - government regulation, FDA approvals can make or break a small biotech company.

Thanks for the response. You're right, and come to think of it, ALT is probably not a good pick at this time.. If 117 was a flop, they're most likely SOL.

That said, I won't miss the money and I'm willing to take some big risks. Any tips?

My best tip is to take the previous advice and avoid biotech stocks unless you're extremely confident in them and have done extensive research and the companies are large enough and have a sufficiently diverse product lineup to be hedged against unforseen events.

Especially avoid small companies ... penny stocks ... low-volume stocks ... and single-product biotech firms.

OTC:SYNI falls into all of the above categories.

There are far, far better places to put your money.

You may think you "won't miss the money," but trust me, in the long run, large-scale economic events outside your control will ensure that you will.

My worst trade so far was a $30k one-day loss on a one-product biotech firm whose one product was suddenly discovered to destroy patients' livers.

Stop giving Wall Street your money. If you absolutely must put your money into the market, buy something with a good risk/reward ratio, like NTDOY.

Edited by resveratrol, 01 April 2010 - 07:43 PM.

[Ghostrider]

If you won't miss the money, then please donate it to SENS or MFoundation.

[kismet]

If you won't miss the money, then please donate it to SENS or MFoundation.

Thins wins the thread.

[revenant]

ALT-711 induced possible hepatic neoplasms in rats, that's not good for business.

http://www.thefreeli......-a0129263393

[YOLF]

ALT-711 induced possible hepatic neoplasms in rats, that's not good for business.

http://www.thefreeli......-a0129263393

This link no longer works. What's thew age of the rats? What kind?

[Rocket]

I liked alt711. Its a bummer I can no longer find it.